Cost Effectiveness in RCC - What is Value and Who gets to decide?

Cost Effectiveness in RCC - What is Value and Who gets to decide?

User Photo
kidneycancer

2 years
1,089 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Robert G. Uzzo, MD of Fox Chase Cancer Center presents his thoughts on the Cost Effectiveness in Renal Cell Carcinoma - What is Value and Who gets to decide? at the 2017 Annual Kidney Cancer Association in Miami, FL
Up Next Autoplay
User Photo